This brand name is authorized in Spain, Hong Kong, Turkey, United States
The drug CAFERGOT contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Ergotamine
UNII MRU5XH3B48 - ERGOTAMINE TARTRATE
|
|
|
|
2
Caffeine
UNII 3G6A5W338E - CAFFEINE
|
|
Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N02CA52 | Ergotamine, combinations excl. psycholeptics | N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CA Ergot alkaloids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 17558 |
| Country: HK | Department of Health Drug Office | Identifier(s): 14176 |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699708011702 |
| Country: US | FDA, National Drug Code | Identifier(s): 0781-5405 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
